LGVN News and Press, Longeveron Inc. From 12/09/21

Up nearly 400% in the last month alone, Longeveron (NASDAQ: LGVN) is doubtlessly one of the more volatile biotechs in the longevity space. Between its brief dalliance with meme stock traders in November and recent progress with regulatory authorities, plenty of people have made a lo...

3 Top Biotech Stocks To Check Out Right Now Like it or not, biotech stocks are becoming an increasingly viable play in the stock market today. By and large, this remains the case as the current coronavirus pandemic lit a fire under the industry. Namely, both seasoned and new investo...

Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The reason for the occurrence of autoimmune disease is because t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With its latest variant (Omicron) spreading, it seems Covid-19 will continue to play a major role in world events in 2022, just like it did in 2020, and in 2021. With this, pandemic-related drug stocks will likely remain ho...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any of Tom’s potential 100x picks, subscribe to his mailing list here . The Insiders Winning the...

HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per year Orphan Drug Designation confers certain benefits and may result in seven year market exclusivity upon approval for this indication if all statutory and regulatory requirements are...

Shares of Longeveron (NASDAQ: LGVN) jumped 661.2% in November, according to data from S&P Global Market Intelligence . The stock surged after it was announced that the company received a Rare Pediatric Disease (RPD) designation for its Lomecel-B treatment. ...

How much would you pay for a chance to stay healthy and vibrant for a few extra decades? An American biotechnology company located in Miami of all places has convinced more than a few investors that its cellular therapy candidate can reverse common effects of aging. This November, share...

MIAMI, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the closing of its previously announced privat...

3 Top Health Care Stocks To Watch In December 2021 As the broader stock market looks to end this rollercoaster ride of a week in the green, one fact remains. Namely, the Omicron Covid variant is the latest hurdle in the fight against the pandemic and health care stocks are o...